Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. (Q33332758)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. |
scientific article |
Statements
1 reference
Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. (English)
1 reference
K Kubota
1 reference
T Tamura
1 reference
M Fukuoka
1 reference
K Furuse
1 reference
H Ikegami
1 reference
Y Ariyoshi
1 reference
Y Kurita
1 reference
N Saijo
1 reference
1 April 2000
1 reference
1 reference
11
1 reference
445-450
1 reference
Identifiers
1 reference
1 reference